← Browse by Condition
Medical Condition
liver transplant
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for liver transplant sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — liver transplant Clinical Trials
How many clinical trials are currently recruiting for liver transplant?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for liver transplant, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for liver transplant?
liver transplant research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a liver transplant clinical trial?
Eligibility criteria for liver transplant trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06813508
Recruiting
Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
Enrollment
1,000 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
NCT06075745 Phase 2
Recruiting
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Enrollment
416 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT05940857
Recruiting
US National OCS Liver Perfusion (OLP) Registry
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
NCT06254248 Phase 2
Recruiting
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Enrollment
50 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06215404
Recruiting
Fluid Management Strategies on Blood Loss in Liver Transplantation
Enrollment
60 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology